PLASMA-PROTEIN BINDING OF FENTANYL - THE EFFECT OF HYPERLIPOPROTEINEMIA AND CHRONIC-RENAL-FAILURE

被引:28
作者
BOWER, S
机构
关键词
D O I
10.1111/j.2042-7158.1982.tb04194.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:102 / 106
页数:5
相关论文
共 20 条
[1]  
ANDREASEN F, 1973, ACTA PHARMACOL TOX, V32, P417
[2]  
ANDREASEN F, 1974, ACTA PHARMACOL TOX, V34, P284
[3]  
ANTON AH, 1971, ACTA PHARM TOXICOL S, V3, P134
[4]  
BOOBIS SW, 1977, CLIN PHARMACOL THER, V22, P147
[5]   PLASMA-PROTEIN BINDING OF FENTANYL [J].
BOWER, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (08) :507-514
[6]  
BOWER S, 1976, BRIT J ANAESTH, V48, P1121
[7]  
DANON A, 1979, CLIN PHARMACOL THER, V25, P316
[8]  
HATCH FT, 1968, ADV LIPID RES, V6, P2, DOI 10.1016/B978-1-4831-9942-9.50008-5
[9]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[10]  
LOSOWSKY MS, 1968, J LAB CLIN MED, V71, P736